OpenURL Connection Search

Select item for more details and to access through your institution.

Cancer Antigen 125 Associated With Multiple Benign and Malignant Pathologies.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2003, v. 10, n. 2, p. 150, doi. 10.1245/ASO.2003.05.015
By:
- Miralles, C.;
- Orea, M.;
- España, P.;
- Provencio, M.;
- Sánchez, A.;
- Cantos, B.;
- Cubedo, R.;
- Carcereny, E.;
- Bonilla, F.;
- Gea, T.
Publication type:
Article
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab.
Published in:
Clinical & Translational Oncology, 2020, v. 22, n. 3, p. 411, doi. 10.1007/s12094-019-02143-6
By:
- Panciroli, C.;
- Lucente, G.;
- Vidal, L.;
- Carcereny, E.;
- Quiroga, V.;
- Pardo, J. C.;
- Romeo, M.;
- Estival, A.;
- Manzano, J. L.;
- Pardo, B.;
- Velarde, J. M.;
- Esteve, A. M.;
- Lopez, D.;
- Mañes, A.;
- Tuset, V.;
- Villà, S.;
- Quintero, C. B.
Publication type:
Article
Consensus on the use of immune-related response criteria to evaluate the efficacy of immunotherapy in non-small cell lung cancer.
Published in:
Clinical & Translational Oncology, 2019, v. 21, n. 11, p. 1464, doi. 10.1007/s12094-019-02072-4
By:
- Provencio, M.;
- Carcereny, E.;
- Artal, Á.
Publication type:
Article
Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program.
Published in:
Clinical & Translational Oncology, 2019, v. 21, n. 9, p. 1270, doi. 10.1007/s12094-019-02053-7
By:
- Corral, J.;
- Majem, M.;
- Rodríguez-Abreu, D.;
- Carcereny, E.;
- Cortes, Á. A.;
- Llorente, M.;
- López Picazo, J. M.;
- García, Y.;
- Domine, M.;
- López Criado, M P.
Publication type:
Article
SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018).
Published in:
Clinical & Translational Oncology, 2019, v. 21, n. 1, p. 3, doi. 10.1007/s12094-018-1978-1
By:
- Majem, M.;
- Juan, O.;
- Insa, A.;
- Reguart, N.;
- Trigo, J. M.;
- Carcereny, E.;
- García-Campelo, R.;
- García, Y.;
- Guirado, M.;
- Provencio, M.
Publication type:
Article
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.
Published in:
Clinical & Translational Oncology, 2017, v. 19, n. 12, p. 1537, doi. 10.1007/s12094-017-1700-8
By:
- Remon, J.;
- Isla, D.;
- Garrido, P.;
- Castro, J.;
- Majem, M.;
- Viñolas, N.;
- Artal, A.;
- Carcereny, E.;
- García-Campelo, M.;
- Lianes, P.;
- Provencio, M.;
- Juan, O.;
- Diz, P.;
- Blanco, R.;
- Lopez-Castro, R.;
- Maestu, I.;
- Vadell, C.;
- Felip, E.
Publication type:
Article
P05.81 Neurocognitive assessment in cancer patients without central nervous system disease treated with bevacizumab at week 34: an observational transversal multi-centric pilot study.
Published in:
Neuro-Oncology, 2018, v. 20, p. iii322, doi. 10.1093/neuonc/noy139.407
By:
- Panciroli, C;
- Lucente, G;
- Cecilia, O;
- Quiroga, V;
- Carcereny, E;
- Pardo, J;
- Romeo, M;
- Velarde, J;
- Villa, S;
- Balaña, C
Publication type:
Article

Found: 7

Cancer Antigen 125 Associated With Multiple Benign and Malignant Pathologies.

Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab.

Consensus on the use of immune-related response criteria to evaluate the efficacy of immunotherapy in non-small cell lung cancer.

Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program.

SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018).

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

P05.81 Neurocognitive assessment in cancer patients without central nervous system disease treated with bevacizumab at week 34: an observational transversal multi-centric pilot study.